• 1. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 2. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 3. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 4. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 5. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248

Introduction to 1-bromo-5-chloroisoquinoline (CAS No. 1207448-41-6)

1-bromo-5-chloroisoquinoline, identified by its Chemical Abstracts Service (CAS) number 1207448-41-6, is a heterocyclic organic compound that has garnered significant attention in the field of medicinal chemistry and pharmaceutical research. This compound belongs to the isoquinoline family, a class of nitrogen-containing aromatic organic compounds known for their diverse biological activities and applications in drug development. The presence of both bromine and chlorine substituents in its molecular structure enhances its reactivity, making it a valuable intermediate in synthetic chemistry and a potential precursor for various pharmacologically active molecules.

The structural framework of 1-bromo-5-chloroisoquinoline consists of a benzene-like ring system fused with a pyridine-like nitrogen-containing ring, with the bromine atom attached at the 1-position and the chlorine atom at the 5-position. This specific substitution pattern imparts unique electronic and steric properties to the molecule, which can be exploited in designing novel chemical entities with tailored biological functions. The compound’s versatility has positioned it as a key building block in the synthesis of more complex molecules, particularly those targeted for therapeutic intervention.

In recent years, there has been growing interest in exploring the pharmacological potential of 1-bromo-5-chloroisoquinoline and its derivatives. Researchers have been investigating its role as a scaffold for developing drugs that modulate various biological pathways. For instance, studies have suggested that isoquinoline derivatives may exhibit anti-inflammatory, antimicrobial, and anticancer properties. The bromo and chloro substituents on 1-bromo-5-chloroisoquinoline are particularly noteworthy, as they provide handles for further functionalization through cross-coupling reactions such as Suzuki-Miyaura or Buchwald-Hartwig couplings. These reactions are pivotal in constructing more intricate molecular architectures, enabling the creation of novel drug candidates with enhanced efficacy and reduced side effects.

One of the most compelling areas of research involving 1-bromo-5-chloroisoquinoline is its application in oncology. Isoquinoline derivatives have shown promise as inhibitors of kinases and other enzymes involved in cancer cell proliferation. The bromine and chlorine atoms serve as points of attachment for developing small-molecule inhibitors that can selectively target tumor cells without harming healthy tissues. Preliminary studies have demonstrated that compounds derived from 1-bromo-5-chloroisoquinoline can disrupt signaling pathways critical for cancer growth, such as the MAPK and PI3K/Akt pathways. These findings highlight the compound’s potential as a lead molecule in the development of next-generation anticancer therapies.

Another exciting avenue of research is the exploration of 1-bromo-5-chloroisoquinoline as a precursor for antiviral agents. The structural motif of isoquinolines is known to interact with viral enzymes, making them suitable candidates for inhibiting viral replication. Researchers have been synthesizing analogs of 1-bromo-5-chloroisoquinoline to identify compounds that can effectively block viral proteases or integrases. The bromine and chlorine substituents facilitate modifications that enhance binding affinity to viral targets, thereby improving therapeutic outcomes. This line of investigation is particularly relevant in light of emerging viral threats and the need for broad-spectrum antiviral drugs.

The synthesis of 1-bromo-5-chloroisoquinoline itself is an intriguing process that showcases modern synthetic methodologies. Traditional approaches involve multi-step sequences involving cyclization reactions followed by halogenation steps. However, recent advances in catalytic systems have enabled more efficient synthetic routes, reducing reaction times and improving yields. For example, palladium-catalyzed cross-coupling reactions have been employed to introduce bromine and chlorine atoms into pre-formed isoquinoline frameworks with high precision. These advancements not only streamline the production of 1-bromo-5-chloroisoquinoline but also open up new possibilities for constructing related derivatives with tailored properties.

The chemical reactivity of 1-bromo-5-chloroisoquinoline makes it an attractive candidate for exploring new synthetic strategies beyond pharmaceutical applications. In materials science, for instance, isoquinoline derivatives have been investigated for their potential use in organic electronics due to their ability to form stable conjugated systems. The bromine and chlorine substituents can be leveraged to modify electronic properties, making these compounds suitable candidates for use in light-emitting diodes (LEDs), organic photovoltaics (OPVs), and other advanced materials.

From a computational chemistry perspective, 1-bromo-5-chloroisoquinoline has been studied to understand its interaction with biological targets at a molecular level. Molecular modeling techniques have been employed to predict binding affinities and identify key interaction points between the compound and its receptors or enzymes. These insights are crucial for rational drug design, allowing researchers to optimize molecular structures before experimental validation. The availability of high-quality crystal structures has further facilitated these studies, providing detailed snapshots of how 1-bromo-5-chloroisoquinoline interacts with its biological partners.

The safety profile of 1-bromo-5-chloroisoquinoline is another critical aspect that has been thoroughly evaluated through both experimental studies and computational modeling. While halogenated isoquinolines are generally well-tolerated under controlled conditions, researchers emphasize the importance of proper handling due to their reactivity. Standard laboratory protocols are followed to ensure safe storage, handling, and disposal procedures are maintained throughout research activities involving this compound.

In conclusion,1-bromo-5-chloroisoquinoline (CAS No. 1207448-41-6) represents a fascinating compound with broad applications across multiple scientific disciplines. Its unique structural features make it an invaluable tool in medicinal chemistry, offering opportunities for developing novel therapeutics targeting various diseases such as cancer and viral infections. Additionally,1-bromo-5-chloroisoquinoline serves as a platform for exploring innovative synthetic methodologies and advanced materials science applications.

As research continues to uncover new applications for this versatile compound,1-bromo-5-chloroisoquinoline is poised to remain at the forefront of chemical innovation,providing critical insights into drug discovery processes while expanding our understanding of molecular interactions at a fundamental level.

• 891842-50-5(2-Bromo-6-chloroquinoline)
• 286949-66-4(1H-Indole,2-bromo-5,6-dichloro-)
• 22918-01-0(2-Bromo-4-chloropyridine)
• 1196155-73-3(1-Bromo-7-chloroisoquinoline)
• 925890-48-8(1-Bromo-4-chloroisoquinoline)
• 1246552-90-8(3-bromo-7-chloroisoquinoline)
• 64658-05-5(2-Bromo-4-chloroquinoline)
• 40473-01-6(2-Bromo-5-chloropyridine)
• 1276056-67-7(3-Bromo-5-chloroisoquinoline)
• 891842-52-7(2-Bromo-8-chloroquinoline)